PMID: 18540901
Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 18540901
Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**

The core question is whether genetic polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes play a role in transient tachypnea of the newborn (TTN). Specifically, it seeks to understand if variations in these genes are associated with an increased risk of TTN in newborns.

**2. Evidence Evaluation**

The abstract presents a study involving 73 term newborns with TTN and 55 healthy controls from a Caucasian cohort. Key findings include:

- **Demographics and Clinical Characteristics:** TTN infants were more likely to be male, had lower birth weight and gestational age, and were more often delivered by cesarean section.
  
- **Genetic Findings:** 
  - The beta1Ser49Gly polymorphism showed a significant difference between TTN cases and controls.
  - Beta1Gly49 homozygotes had a higher risk of developing TTN (OR 18.5; 95%CI 1.5-229; p = 0.023) compared to beta1Ser49 allele carriers.
  - The T-47C, A46G, C79G, and C491T (TACC) haplotype in the ADRB2 gene was significantly associated with TTN (p = 0.048).
  
- **Conclusion of the Study:** The researchers concluded that both beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, which are loss-of-function genetic variations, may predispose newborns to TTN.

The evidence is robust, showing significant associations between specific ADRB gene polymorphisms and the occurrence of TTN. However, limitations such as sample size and population specificity should be considered when generalizing the findings.

**3. Conclusion**

Based on the study's findings, there is a clear association between polymorphisms in the ADRB encoding genes and the risk of TTN in newborns. The identified genetic variations (beta1Gly49 homozygosity and TACC haplotype) significantly increase the likelihood of developing TTN, indicating that these polymorphisms play a role in the condition.

**4. Final Answer**

**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether polymorphisms in the beta-adrenergic receptor (ADRB) genes are associated with Transient Tachypnea of the Newborn (TTN). Key evidence to identify includes genetic variants (e.g., beta1Ser49Gly polymorphism, ADRB2 haplotypes) and their statistical associations with TTN in the study’s cohort.  

**2. Evidence Evaluation**  
- **Beta1Ser49Gly Polymorphism**: The study found that beta1Gly49 homozygotes had a significantly higher risk for TTN (OR 18.5; 95% CI 1.5–229; p=0.023) compared to carriers of the beta1Ser49 allele. This suggests a strong association, though the wide confidence interval indicates some uncertainty.  
- **ADRB2 TACC Haplotype**: The TACC haplotype (comprising T-47C, A46G, C79G, and C491T polymorphisms) was significantly associated with TTN (p=0.048).  
- **Conclusion of the Study**: The abstract explicitly states that both the beta1Gly49 homozygosity and the TACC haplotype (loss-of-function variations) "may predispose to TTN," indicating a plausible role for these genetic factors.  
- **Confounding Factors**: While TTN infants had lower birth weight, gestational age, and higher cesarean section rates, the multivariate analysis likely adjusted for these variables, as the associations remained significant.  

**3. Conclusion**  
The study provides statistically significant evidence (albeit with some limitations like small sample size and wide CI for beta1Gly49) linking specific ADRB gene polymorphisms (beta1Ser49Gly and ADRB2 TACC haplotype) to TTN. The abstract’s conclusion supports a role for these genetic variants, warranting a "yes" answer.  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether polymorphisms in beta-adrenergic receptor (ADRB) genes play a role in transient tachypnea of the newborn (TTN). Key information to identify includes genetic associations between ADRB polymorphisms (e.g., beta1Ser49Gly, ADRB2 haplotypes) and TTN risk.

**2. Evidence Evaluation**  
- The study identified significant differences in the beta1Ser49Gly polymorphism between TTN cases and controls, with beta1Gly49 homozygotes showing an 18.5-fold increased risk (OR 18.5; p=0.023).  
- A TACC haplotype in the ADRB2 gene was also significantly associated with TTN (p=0.048).  
- Both genetic variations are described as loss-of-function, plausibly impairing lung fluid clearance, a key mechanism in TTN.  
- Strengths include multivariate analysis adjusting for confounders and statistical significance. Limitations include a small sample size (73 cases, 55 controls) and wide confidence intervals (e.g., 1.5–229), reducing precision.  

**3. Conclusion**  
The abstract provides statistically significant evidence linking ADRB polymorphisms (beta1Gly49 homozygosity and ADRB2 TACC haplotype) to TTN risk. Despite limitations, the findings directly address the question and support a "yes" answer.  

**4. Final Answer**  
**My final choice is: yes**
DeepSeek selected: yes

Initial consensus: All models selected yes